Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBASP vs Escitalopram in Chronic Major Depression
NCT00837564Phase 3Unknown
- Sponsor
- University Hospital Freiburg
- Start
- Feb 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in major depressive disorder (MDD), sponsored by University Hospital Freiburg. Status: unknown.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00837564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837564.